Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

DOJ Cracks Down on COVID-19 Related Fraud

Mar 27, 2020 | COVID-19 Related Law, Cyber Law, False Claims Act, General, Health Care

According to a press release by the Department of Justice (“DOJ”), numerous fraud schemes have developed related to the COVID-19 pandemic. In a March 16 memo to U.S. attorneys, Attorney General William Barr directed the DOJ to “remain vigilant in detecting,...

Florida Pain Doctor Settles False Claims Act Investigation Months After Partner Pleads Guilty to Kickback Scheme

Dec 27, 2018 | False Claims Act

On December 20, 2018, the U.S. Attorney’s Office for the Middle District of Florida announced that a Fort Meyers-based pain doctor had agreed to settle a False Claims Act investigation. Dr. Jonathan Daitch agreed to pay over $1.7 million to resolve allegations that he...

New Federal Kickback Statute Poses Severe Risks for Clinical Laboratories That Pay Commissions to Sales and Marketing Personnel

Dec 27, 2018 | False Claims Act

In October 2018, the Eliminating Kickbacks in Recovery Act of 2018 (“EKRA”) became effective. EKRA will have an immediate and significant effect on the marketing and sales activities of clinical laboratories, clinical treatment facilities, and recovery homes. EKRA, in...

AmerisourceBergen Agrees to Pay $625 Million to Settle Civil Fraud Claims

Nov 22, 2018 | False Claims Act

The U.S. Department of Justice recently announced that AmerisourceBergen Corp. (ABC) and several of its subsidiaries will pay $625 million to settle various allegations that it illegally repackaged and sold adulterated and unapproved new drugs, and that it double...

Federal Court Denies Plaintiff’s Attempt to Name CEO as Defendant In FCA Retaliation Suit

Dec 27, 2017 | False Claims Act

On December 6, 2017, U.S. District Judge Andrew L. Carter Jr. (Southern District of New York) held that a False Claims Act (FCA) whistleblower could not name his boss as an individual defendant in a suit alleging unlawful retaliation. The plaintiff, Gerard Diffley,...

CMS AND OIG PROPOSE CHANGES TO REGULATIONS GOVERNING STATE MEDICAID FRAUD CONTROL UNITS

Oct 6, 2016 | False Claims Act, Health Care

On September 20, 2016, the Department of Health and Human Services’ Office of Inspector General (“OIG”) and Centers for Medicare and Medicaid Services (“CMS”) issued a proposed rule to amend the regulations governing state Medicaid Fraud Control Units (“MFCUs”). State...
« Older Entries
Next Entries »

Recent Posts

  • Kendrick 1, Drake 0: Federal Judge Dismisses Drake’s Claims Against Distributor Over Kendrick Lamar Diss Track
  • Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act
  • Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement
  • Condo Conversion Planned for 2460 Peachtree Road
  • HHS-OIG Expresses “Major Concerns” About Skin Substitutes

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group